Rheumatology

Latest News

biologics and money | Image credit: gopixa - stock.adobe.com
Study: More Biosimilar Competition Is Not Lowering Patient OOP Costs

March 29th 2024

Despite more biosimilars entering the market and generating significant savings for payers and health care systems, these savings are not resulting in lower out-of-pocket (OOP) costs for patients, according to a recent study.

digestive tract | Image credit: Aliaksandr Marko - stock.adobe.com
Physician and Patient Perspectives After Starting or Switching to Amgevita in IBD

March 23rd 2024

psorasis | Image credit: SergeVo - stock.adobe.com
AAD Posters Examine Clinical Effects of Switching to Ustekinumab, Adalimumab Biosimilars

March 20th 2024

slow uptake shown with guy riding snail | Image credit: Nuthawut - stock.adobe.com
Webinar Addresses Solutions to Improve Adalimumab Biosimilar Uptake

March 18th 2024

globe health care | Image credit: Planetz - stock.adobe.com
Adalimumab Expenditures in Countries With and Without Available Biosimilars

March 16th 2024

Video Series
Video Interviews
Podcasts
CFB podcast banner
CFB podcas
CFB podcast banner
CFB podcast banner
cfb podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
"When Choice Arrives: Competition & Consequences" written over a bright blue syringe with the AJMC/The Center for Biosimilars logo in the bottom right corner
podcast banner
Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.